(Información remitida por la empresa firmante)
GOTHENBURG, Sweden, Dec. 5, 2022 /PRNewswire/ —
Zinzino group revenue increased with a total of 13%, compared with the previous year.
The revenue in November for Zinzino’s sales markets increased by 13% and amounted to SEK 159.6 (140.8) million. Faun Pharma’s external sales increased by 5% and amounted to SEK 5.8 (5.5) million. Overall, the Group increased revenues by 13% to SEK 165.4 (146.3) million compared with the previous year.
Accumulated revenue for January – November 2022 increased by 7% to SEK 1312.6 (1222.4) million.
Revenues were distributed as follows:
Countries in regions:
–The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
–South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
–The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
This disclosure contains information that Zinzino is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 05-12-202211:00 CET.
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-november-2022-301694438.html